Oppenheimer Asset Management Inc. Takeda Pharmaceutical CO LTD Transaction History
Oppenheimer Asset Management Inc.
- $7.94 Billion
- Q4 2024
A detailed history of Oppenheimer Asset Management Inc. transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Oppenheimer Asset Management Inc. holds 59,051 shares of TAK stock, worth $847,972. This represents 0.01% of its overall portfolio holdings.
Number of Shares
59,051
Previous 197,199
70.06%
Holding current value
$847,972
Previous $2.8 Million
72.13%
% of portfolio
0.01%
Previous 0.03%
Shares
25 transactions
Others Institutions Holding TAK
# of Institutions
338Shares Held
68.6MCall Options Held
1.72MPut Options Held
178K-
Capital Research Global Investors Los Angeles, CA13.2MShares$189 Million0.04% of portfolio
-
Morgan Stanley New York, NY5.6MShares$80.4 Million0.01% of portfolio
-
Goldman Sachs Group Inc New York, NY4.63MShares$66.5 Million0.01% of portfolio
-
Arrowstreet Capital, Limited Partnership Boston, MA4.22MShares$60.5 Million0.05% of portfolio
-
First Trust Advisors LP Wheaton, IL3.24MShares$46.5 Million0.04% of portfolio
About TAKEDA PHARMACEUTICAL CO LTD
- Ticker TAK
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 3,109,050,112
- Market Cap $44.6B
- Description
- Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...